
Opinion|Videos|May 3, 2024
Treating a DME Patient Lost to Follow-Up with a Highly Durable Agent
Katherine Talcott, MD, presents the case of a patient with diabetic macular edema, and the rest of the panel share their clinical experiences and discuss factors that inform the utilization of more durable agents.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA guidance to help accelerate cell and gene therapies
2
Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema
3
Closing the gap: John Berdahl, MD, on the global cataract burden and the emerging dementia connection
4
The Residency Report: Cardiovascular risk scores as a window into ocular disease
5






















